Welcome to our dedicated page for Weed SEC filings (Ticker: BUDZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating trial budgets, landrace IP details, or insider moves inside WEED Inc.’s cannabis research filings can be a challenge—each 10-K or 8-K mixes biotech jargon with shifting regulations across four continents. Stock Titan solves that problem by turning dense disclosures into clear insights the moment they hit EDGAR.
Our AI-powered engine delivers real-time summaries of every form: a 10-Q becomes an easy-to-scan breakdown of burn rate and consumer packaged-goods revenue; an 8-K flags new cultivation licenses within minutes. Need the exact numbers executives file? The platform streams WEED Inc. Form 4 insider transactions real-time, making it simple to monitor executive stock movements before material announcements.
Type a natural question—“WEED Inc. insider trading Form 4 transactions” or “How to read the WEED Inc. quarterly earnings report 10-Q filing”—and you’ll land on answers that connect filing sections to what matters: cannabinoid trial milestones, international expansion costs, and rare strain licensing fees. You can also dive into:
- WEED Inc. annual report 10-K simplified—AI pulls out segment performance and risk factors.
- WEED Inc. proxy statement executive compensation—instant tables on equity awards.
- WEED Inc. 8-K material events explained—context for every partnership or regulatory update.
Whether you’re understanding WEED Inc. SEC documents with AI or comparing quarters, Stock Titan delivers comprehensive coverage, timely alerts, and professional analysis so you spend minutes—not hours—extracting value from every filing.
WEED, Inc. filed an amended quarterly report for the period ended September 30, 2025, stating the amendment is solely to add iXBRL files and does not change previously reported results. The company generated no revenue for the three and nine months ended September 30, 2025. It reported a net loss of $73,946 for the quarter and $622,018 for the nine-month period, compared with a nine-month net loss of $377,492 a year earlier. Operating expenses for the nine months were $600,805, driven mainly by general and administrative costs of $505,836 and professional fees of $70,413. At September 30, 2025, WEED held $400 in cash, total assets of $532,267, and total liabilities of $1,051,346, resulting in a stockholders’ deficit of $519,079. The company has an accumulated deficit of $85,525,296, continues to rely on related-party loans and stock issued for services, and discloses substantial doubt about its ability to continue as a going concern. As of August 13, 2025, there were 135,932,685 shares of common stock outstanding.
WEED, Inc. reported no revenue for the three and nine months ended September 30, 2025 and continues to operate at a loss. The company recorded a net loss of
Liquidity is very tight: cash fell to
BUDZ filed a notice under Rule 144 for a planned sale of restricted shares. The filing indicates that an affiliate intends to sell 277,683 shares of common stock through broker Wilson Davis, with an aggregate market value of $27,768.00, on or around December 1, 2025 on the OTCQB market. The company reports that there were 123,482,685 shares of common stock outstanding at the time referenced in the notice, which serves as a baseline ownership figure.
The seller originally acquired 2,000,000 common shares from the issuer on October 27, 2016 as part of an employment-related transaction, with the consideration described as services. By signing the notice, the seller represents that they do not know of any material adverse information about BUDZ’s current or prospective operations that has not been publicly disclosed.
WEED, Inc. (BUDZ) filed a Form 12b-25 (NT 10-Q) notifying a late filing of its Quarterly Report on Form 10‑Q for the period ended September 30, 2025.
The company indicated the Form 10‑Q will be filed on or before the fifth calendar day following the prescribed due date, consistent with Rule 12b‑25(b)(2)(ii). WEED, Inc. stated the report could not be filed within the required time without unreasonable effort and expense and noted it is completing its financial statement review.
FAQ
What is the current stock price of Weed (BUDZ)?
What is the market cap of Weed (BUDZ)?
